Home › Companies › GENERATION BIO CO. › 2023-2024
Compiled from SEC Form N-PX filings and GENERATION BIO CO.’s Form 8-K, filed June 7, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 6, 2024: 5 items on GENERATION BIO CO.’s Form 8-K, filed June 7, 2024: 2 approved · 3 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024
Explore GENERATION BIO CO. in the interactive database Compare manager voting policies
These tallies are GENERATION BIO CO.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 7, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jeffrey Jonas, M.D. | 35,807,200 | -- | -- | 12,353,347 | 5,410,328 | 74% | Not verified | — |
| Elect Director: Geoff McDonough, M.D. | 47,658,822 | -- | -- | 501,725 | 5,410,328 | 99% | Not verified | — |
| Elect Director: Donald Nicholson, Ph.D. | 47,589,073 | -- | -- | 571,474 | 5,410,328 | 99% | Not verified | — |
| 2. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 53,562,165 | 1,795 | 6,915 | -- | -- | 99.9% | Approved | — |
| 3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers | 47,772,176 | 373,246 | 15,125 | -- | 5,410,328 | 99.2% | Approved | — |
Source: GENERATION BIO CO., Form 8-K, filed with the SEC on June 7, 2024 — read the filing on EDGAR.
Each item below shows how the 109 asset managers that disclosed a GENERATION BIO CO. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I directors to our board of directors, each to serve until the 2027 Annual Meeting of Stockholders: Geoff McDonough
GENERATION BIO CO.’s own tally for this item (“Elect Director: Geoff McDonough, M.D.”): 47,658,822 for, 501,725 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 17,504,814 for, 322,141 withheld, 15,831 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 7,594,583 | 0 | 0 | 0 | For |
| Fidelity | 4,384,109 | 0 | 0 | 0 | For |
| Vanguard | 2,533,447 | 0 | 0 | 0 | For |
| BlackRock | 1,143,240 | 0 | 0 | 0 | For |
| Charles Schwab | 389,451 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 318,340 | Withhold |
| BRIDGEWAY FUNDS INC | 241,600 | 0 | 0 | 0 | For |
| Goldman Sachs | 219,730 | 0 | 0 | 0 | For |
| SEI | 215,561 | 0 | 0 | 0 | For |
| Equitable | 178,978 | 0 | 0 | 0 | For |
| TIAA | 148,392 | 0 | 0 | 0 | For |
| John Hancock | 101,820 | 0 | 4,046 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,184 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 44,094 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,000 | 0 | 0 | 2,510 | Mixed |
| AIG/SunAmerica | 22,317 | 0 | 0 | 0 | For |
| Northern Trust | 21,499 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,778 | 0 | 0 | 0 | For |
| Pacific Life | 18,619 | 0 | 0 | 0 | For |
| Nationwide | 17,332 | 0 | 0 | 0 | For |
| State Street | 16,681 | 0 | 0 | 0 | For |
| Voya | 16,253 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 12,800 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 11,785 | 0 | Abstain |
| American Century | 10,895 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I directors to our board of directors, each to serve until the 2027 Annual Meeting of Stockholders: Donald Nicholson
GENERATION BIO CO.’s own tally for this item (“Elect Director: Donald Nicholson, Ph.D.”): 47,589,073 for, 571,474 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 17,436,619 for, 390,336 withheld, 15,831 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 7,594,583 | 0 | 0 | 0 | For |
| Fidelity | 4,384,109 | 0 | 0 | 0 | For |
| Vanguard | 2,533,447 | 0 | 0 | 0 | For |
| BlackRock | 1,143,240 | 0 | 0 | 0 | For |
| Charles Schwab | 389,451 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 318,340 | Withhold |
| BRIDGEWAY FUNDS INC | 241,600 | 0 | 0 | 0 | For |
| Goldman Sachs | 219,730 | 0 | 0 | 0 | For |
| SEI | 215,561 | 0 | 0 | 0 | For |
| Equitable | 110,783 | 0 | 0 | 68,195 | Mixed |
| TIAA | 148,392 | 0 | 0 | 0 | For |
| John Hancock | 101,820 | 0 | 4,046 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,184 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 44,094 | 0 | 0 | 0 | For |
| Lincoln Financial | 39,000 | 0 | 0 | 2,510 | Mixed |
| AIG/SunAmerica | 22,317 | 0 | 0 | 0 | For |
| Northern Trust | 21,499 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,778 | 0 | 0 | 0 | For |
| Pacific Life | 18,619 | 0 | 0 | 0 | For |
| Nationwide | 17,332 | 0 | 0 | 0 | For |
| State Street | 16,681 | 0 | 0 | 0 | For |
| Voya | 16,253 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 12,800 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 11,785 | 0 | Abstain |
| American Century | 10,895 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
Combines 3 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Description as filed by funds: Election of three Class I directors to our board of directors, each to serve until the 2027 Annual Meeting of Stockholders: Jeffrey Jonas
GENERATION BIO CO.’s own tally for this item (“Elect Director: Jeffrey Jonas, M.D.”): 35,807,200 for, 12,353,347 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 13,985,696 for, 3,773,930 withheld, 83,160 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 7,594,583 | 0 | 0 | 0 | For |
| Fidelity | 4,384,109 | 0 | 0 | 0 | For |
| Vanguard | 0 | 0 | 0 | 2,533,447 | Withhold |
| BlackRock | 1,143,240 | 0 | 0 | 0 | For |
| Charles Schwab | 389,451 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 318,340 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 241,600 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 219,730 | Withhold |
| SEI | 0 | 0 | 0 | 215,561 | Withhold |
| Equitable | 110,783 | 0 | 0 | 68,195 | Mixed |
| TIAA | 148,392 | 0 | 0 | 0 | For |
| John Hancock | 83,285 | 0 | 22,581 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 79,184 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 0 | 0 | 44,094 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 0 | 41,510 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 22,317 | Withhold |
| Northern Trust | 0 | 0 | 0 | 21,499 | Withhold |
| Bridge Builder Trust | 18,778 | 0 | 0 | 0 | For |
| Pacific Life | 18,619 | 0 | 0 | 0 | For |
| Nationwide | 566 | 0 | 0 | 16,766 | Withhold |
| State Street | 0 | 0 | 0 | 16,681 | Withhold |
| Voya | 0 | 0 | 0 | 16,253 | Withhold |
| TARGET PORTFOLIO TRUST | 12,800 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 11,785 | 0 | Abstain |
| American Century | 0 | 0 | 0 | 10,895 | Withhold |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
Combines 8 wordings of this item as funds reported it.
99.2% Approved · of votes cast
Description as filed by funds: Approval, on an advisory (non- binding) basis, of the compensation of our named executive officers.
GENERATION BIO CO.’s own tally for this item (“3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers”): 47,772,176 for, 373,246 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the stockholders of the Company approved, on an advisory (non-binding) basis, of the compensation of its named executive officers.”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 7,594,583 | 0 | 0 | 0 | For |
| Fidelity | 4,384,109 | 0 | 0 | 0 | For |
| Vanguard | 2,533,447 | 0 | 0 | 0 | For |
| BlackRock | 1,143,240 | 0 | 0 | 0 | For |
| Charles Schwab | 389,451 | 0 | 0 | 0 | For |
| Dimensional | 318,340 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 241,600 | 0 | 0 | Against |
| Goldman Sachs | 219,730 | 0 | 0 | 0 | For |
| SEI | 215,561 | 0 | 0 | 0 | For |
| Equitable | 178,978 | 0 | 0 | 0 | For |
| TIAA | 148,392 | 0 | 0 | 0 | For |
| John Hancock | 105,866 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,184 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 44,094 | 0 | 0 | 0 | For |
| Lincoln Financial | 41,510 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,317 | 0 | 0 | 0 | For |
| Northern Trust | 21,499 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,778 | 0 | 0 | 0 | For |
| Pacific Life | 18,619 | 0 | 0 | 0 | For |
| Nationwide | 17,332 | 0 | 0 | 0 | For |
| State Street | 16,681 | 0 | 0 | 0 | For |
| Voya | 16,253 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 12,800 | 0 | 0 | 0 | For |
| Jackson National | 11,785 | 0 | 0 | 0 | For |
| American Century | 0 | 10,895 | 0 | 0 | Against |
Fund voting reports, all 38 managers: 17,587,014 for, 255,772 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 9,436,058 | 0 | 0 | 0 | For |
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | 0 | 0 | 0 | For |
| Fidelity | 5,331,181 | 0 | 0 | 0 | For |
| EcoR1 Capital, LLC | 2,046,867 | 0 | 0 | 0 | For |
| PFM Health Sciences, LP | 1,622,487 | 0 | 0 | 0 | For |
| BlackRock | 1,125,147 | 593 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,069,389 | 0 | 0 | 0 | For |
| State Street | 917,755 | 46 | 0 | 0 | For |
| Goldman Sachs | 838,643 | 0 | 0 | 0 | For |
| Charles Schwab | 389,451 | 0 | 0 | 0 | For |
| Renaissance | 245,486 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 241,600 | 0 | 0 | Against |
| DE Shaw | 228,248 | 0 | 0 | 0 | For |
| SEI | 215,563 | 0 | 0 | 0 | For |
| Northern Trust | 206,962 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 196,715 | 0 | 0 | 0 | For |
| JPMorgan | 196,499 | 0 | 0 | 0 | For |
| Two Sigma | 194,837 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 175,974 | 0 | 0 | 0 | For |
| Nuveen | 150,965 | 0 | 0 | 0 | For |
| Yiheng Capital Management, L.P. | 149,976 | 0 | 0 | 0 | For |
| Dimensional | 123,594 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 81,207 | 0 | 0 | 0 | For |
| AllianceBernstein | 68,195 | 0 | 0 | 0 | For |
| Vanguard | 42,949 | 0 | 0 | 0 | For |
Institutional-manager reports, all 83 managers: 33,588,693 for, 295,658 against. Showing the 25 largest; see all in the interactive database.
99.9% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
GENERATION BIO CO.’s own tally for this item (“2. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 53,562,165 for, 1,795 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm to serve for the year ending December 31, 2024.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 17,842,786 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 7,594,583 | 0 | 0 | 0 | For |
| Fidelity | 4,384,109 | 0 | 0 | 0 | For |
| Vanguard | 2,533,447 | 0 | 0 | 0 | For |
| BlackRock | 1,143,240 | 0 | 0 | 0 | For |
| Charles Schwab | 389,451 | 0 | 0 | 0 | For |
| Dimensional | 318,340 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 241,600 | 0 | 0 | 0 | For |
| Goldman Sachs | 219,730 | 0 | 0 | 0 | For |
| SEI | 215,561 | 0 | 0 | 0 | For |
| Equitable | 178,978 | 0 | 0 | 0 | For |
| TIAA | 148,392 | 0 | 0 | 0 | For |
| John Hancock | 105,866 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,184 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 44,094 | 0 | 0 | 0 | For |
| Lincoln Financial | 41,510 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,317 | 0 | 0 | 0 | For |
| Northern Trust | 21,499 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,778 | 0 | 0 | 0 | For |
| Pacific Life | 18,619 | 0 | 0 | 0 | For |
| Nationwide | 17,332 | 0 | 0 | 0 | For |
| State Street | 16,681 | 0 | 0 | 0 | For |
| Voya | 16,253 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 12,800 | 0 | 0 | 0 | For |
| Jackson National | 11,785 | 0 | 0 | 0 | For |
| American Century | 10,895 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 66,528,840 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 11.42% |
| 2 | Fidelity | 6.59% |
| 3 | Vanguard | 3.81% |
| 4 | BlackRock | 1.72% |
| 5 | Charles Schwab | 0.59% |
| 6 | Dimensional | 0.48% |
| 7 | BRIDGEWAY FUNDS INC | 0.36% |
| 8 | Goldman Sachs | 0.33% |
| 9 | SEI | 0.32% |
| 10 | Equitable | 0.27% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 14.18% |
| 2 | Atlas Venture Life Science Advisors, LLC | 12.44% |
| 3 | Fidelity | 8.01% |
| 4 | EcoR1 Capital, LLC | 3.08% |
| 5 | PFM Health Sciences, LP | 2.44% |
| 6 | BlackRock | 1.69% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.61% |
| 8 | State Street | 1.38% |
| 9 | Goldman Sachs | 1.26% |
| 10 | Charles Schwab | 0.59% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| T. Rowe Price | 13.35% | 13F |
| Jason Rhodes | 12.61% | DEF14A |
| Entities affiliated with Atlas Venture Life Science Advisors | 12.44% | DEF14A |
| Entities affiliated with T Rowe Price Associates | 10.41% | DEF14A |
| ModernaTX | 8.81% | DEF14A |
| Entities affiliated with Fidelity Investment | 8.05% | DEF14A |
| Entities affiliated with BB Biotech AG | 5.42% | DEF14A |
| BB Biotech AG | 4.98% | 13G |
| Geoff McDonough, M.D. | 3.84% | DEF14A |
| Geode Capital | 1.61% | 13F |
Percentages above are of 66,528,840 shares outstanding, as reported by GENERATION BIO CO. on its Form 10-Q dated May 8, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from GENERATION BIO CO.’s 10-Q dated May 8, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At GENERATION BIO CO.'s shareholder meeting held June 6, 2024, in the 2023-2024 proxy season, 109 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 730 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory (non- binding) basis, of the compensation of our named executive… — GENERATION BIO CO.'s filing reports the proposal as approved, with 99.2% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: GENERATION BIO CO.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 7, 2024.
GENERATION BIO CO. proxy season coverage: 2023-2024 (this page).
Download data (CSV): ballot items · votes by manager · column guide.